RecruitingNot ApplicableNCT05302583

Aromatherapy Inhaler Use for HSCT Distress

Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress

Sponsor

Stanford University

Enrollment

50 participants

Start Date

Jun 16, 2025

Study Type

INTERVENTIONAL

Conditions

Cancer Distress Aromatherapy Cancer Coping Hematopoetic Stem Cell Transplant

Summary

The purpose of this research is to evaluate aromatherapy inhaler use and how it may impact cancer distress and coping by patients in the first few days after hematopoietic stem cell transplant (HSCT).

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using a personal aromatherapy inhaler with lavender or peppermint essential oils helps reduce anxiety, nausea, and distress in adults undergoing stem cell transplantation (HSCT) for blood cancers. Participants receive the inhaler during their hospital stay. You may be eligible if... - You are 19 or older - You are being admitted for a planned stem cell transplant (autologous or allogeneic) for a blood cancer - You received chemotherapy as part of your preparative regimen - You have no allergies to lavender or peppermint essential oils - You speak, read, and understand English You may NOT be eligible if... - You are admitted for CAR-T cell infusion - You have scleroderma, atrial fibrillation, or G6PD deficiency - You have known allergies to lavender or peppermint - You are a pediatric patient (18 or younger) - You are being admitted unexpectedly (e.g., for fever or deterioration) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.